[1]
2026. Glucagon-like Peptide-1 Medicines for Peripheral Arterial Disease in Type 2 Diabetes: Are They Ready for Prime Time?. Canadian Diabetes & Endocrinology Today. 4, 1 (May 2026), 5–9. DOI:https://doi.org/10.58931/cdet.2026.4149.